Retour
Fourchette du Jour
24,86 €
27,02 €
Fourchette 52 Semaines
0,55 €
83,60 €
Volume
112 793
Moyenne 50J / 200J
28,38 €
/
20,03 €
Clôture Précédente
27,37 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3478,7 | 0,4 |
| P/B | 2565,4 | 2,9 |
| ROE % | -54,8 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
Points Clés
Debt/Equity of 0,11 — conservative balance sheet
Negative free cash flow of -3,27M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-54,81%
ROIC-52,32%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,11
Current Ratio7,39
Interest Coverage0,00
Valorisation
P/E Ratio
-3478,74
P/B Ratio2565,40
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -3,58M |
| ROE | -54,81% | ROA | -62,27% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3,27M |
| ROIC | -52,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 7,39 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3478,74 | P/B Ratio | 2565,40 |
| P/S Ratio | N/A | PEG Ratio | 136,35 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 12,47B | Enterprise Value | 12,47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -3,58M | -4,30M | -5,87M | -7,42M | -1,35M |
| EPS (Diluted) | -0,01 | -0,01 | -0,01 | -0,02 | 0,00 |
| Gross Profit | -392 743,0 | -745 588,0 | -769 687,0 | -604 397,0 | -26 456,0 |
| Operating Income | -3,77M | -4,74M | -6,27M | -7,62M | -1,38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,76M | 8,44M | 12,62M | 18,02M | 340 134,0 |
| Total Liabilities | 895 308,0 | 219 512,0 | 632 320,0 | 938 032,0 | 4,34M |
| Shareholders' Equity | 4,86M | 8,22M | 12,03M | 17,07M | -4,00M |
| Total Debt | 544 415,0 | 85 741,0 | 463 669,0 | 771 255,0 | 3,68M |
| Cash & Equivalents | 2,42M | 2,96M | 1,56M | 6,42M | 59 413,0 |
| Current Assets | 4,90M | 8,11M | 11,62M | 16,44M | 66 849,0 |
| Current Liabilities | 663 673,0 | 193 578,0 | 606 914,0 | 577 764,0 | 4,34M |